Protagonist Therapeutics, Inc Prepaid Insurance
Protagonist Therapeutics, Inc (PTGX) had Prepaid Insurance of $605.00 thousand as of 2026-06-30, per its 10-Q filed 2026-08-05.
Financial Statements › Balance Sheet › Assets › Assets, Current › Prepaid Expense, Current
us-gaap:PrepaidInsurance · last filed 2026-08-05
- 2026-06-30: Prepaid Insurance $605.00K.
- 2026-03-31: Prepaid Insurance $1.09M.
- 2025-12-31: Prepaid Insurance $1.06M.
- 2025-09-30: Prepaid Insurance $174.00K.
| Period end | Prepaid Insurance |
|---|---|
| 2026-06-30 | $605.00K 10-Q · filed 2026-08-05 |
| 2026-03-31 | $1.09M 10-Q · filed 2026-05-05 |
| 2025-12-31 | $1.06M 10-Q · filed 2026-08-05 |
| 2025-09-30 | $174.00K 10-Q · filed 2025-11-06 |
| 2025-06-30 | $582.00K 10-Q · filed 2025-08-06 |
| 2025-03-31 | $1.07M 10-Q · filed 2025-05-06 |
| 2024-12-31 | $1.16M 10-K · filed 2026-02-25 |
| 2024-09-30 | $217.00K 10-Q · filed 2024-11-07 |
| 2024-06-30 | $880.00K 10-Q · filed 2024-08-06 |
| 2024-03-31 | $1.33M 10-Q · filed 2024-05-07 |
| 2023-12-31 | $1.41M 10-K · filed 2025-02-21 |
| 2023-09-30 | $1.87M 10-Q · filed 2023-11-02 |
| 2023-06-30 | $827.00K 10-Q · filed 2023-08-03 |
| 2023-03-31 | $1.40M 10-Q · filed 2023-05-04 |
| 2022-12-31 | $1.42M 10-K · filed 2024-02-27 |
| 2022-09-30 | $436.00K 10-Q · filed 2022-11-08 |
| 2022-06-30 | $876.00K 10-Q · filed 2022-08-04 |
| 2022-03-31 | $1.43M 10-Q · filed 2022-05-05 |
| 2021-12-31 | $1.75M 10-K · filed 2023-03-15 |
| 2020-12-31 | $1.44M 10-K · filed 2022-02-28 |
| 2019-12-31 | $1.16M 10-K · filed 2021-03-10 |
| 2018-12-31 | $438.00K 10-K · filed 2020-03-10 |
| 2017-12-31 | $378.00K 10-K · filed 2019-03-12 |
| 2016-12-31 | $408.00K 10-K · filed 2018-03-07 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| TG THERAPEUTICS, INC. (TGTX) | United States | $8.805B | 19.05 |
| CYTOKINETICS INC (CYTK) | United States | $9.130B | -11.86 |
| ARROWHEAD PHARMACEUTICALS, INC. (ARWR) | United States | $9.331B | -42.28 |
| Praxis Precision Medicines, Inc. (PRAX) | United States | $7.884B | -27.60 |
| Structure Therapeutics Inc. (GPCR) | United States | $7.710B | -53.41 |
| Spyre Therapeutics, Inc. (SYRE) | United States | $7.685B | -43.69 |
| Axsome Therapeutics, Inc. (AXSM) | United States | $10.274B | -66.82 |
| IONIS PHARMACEUTICALS INC (IONS) | United States | $7.277B | -23.25 |
| Alkermes plc. (ALKS) | $6.844B | 132.74 | |
| RHYTHM PHARMACEUTICALS, INC. (RYTM) | United States | $6.771B | -37.20 |